Tofacitinib Extended-Release Tablets and Von willebrand factor recombinant Intravenous
Determining the interaction of Tofacitinib Extended-Release Tablets and Von willebrand factor recombinant Intravenous and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: tofacitinib
Brand name: Xeljanz, Xeljanz XR
Synonyms: Tofacitinib
Generic Name: von willebrand factor
Brand name: Vonvendi, Wilfactin
Synonyms: Von Willebrand factor (recombinant), von Willebrand Factor (Recombinant)
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Tofacitinib Extended-Release Tablets-Vonvendi
- Tofacitinib Extended-Release Tablets-Vopac
- Tofacitinib Extended-Release Tablets-Vopac MDS
- Tofacitinib Extended-Release Tablets-Vorapaxar
- Tofacitinib Extended-Release Tablets-Vorapaxar Sulfate
- Tofacitinib Extended-Release Tablets-Voraxaze
- Von willebrand factor recombinant Intravenous-Tofacitinib Tablets
- Von willebrand factor recombinant Intravenous-Tofranil
- Von willebrand factor recombinant Intravenous-Tofranil injection
- Von willebrand factor recombinant Intravenous-Tofranil-PM
- Von willebrand factor recombinant Intravenous-Tol-Tab
- Von willebrand factor recombinant Intravenous-Tolazamide